4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To evaluate the safety and tolerability of the intravenous administration of Cx611, a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with refractory rheumatoid arthritis (RA), as well as to obtain preliminary clinical efficacy data in this population.

          Related collections

          Author and article information

          Journal
          Ann. Rheum. Dis.
          Annals of the rheumatic diseases
          BMJ
          1468-2060
          0003-4967
          Jan 2017
          : 76
          : 1
          Affiliations
          [1 ] Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain.
          [2 ] Hospital Universitario Clínico San Carlos de Madrid, Madrid, Spain.
          [3 ] Hospital General Universitario Gregorio Marañón, Madrid, Spain.
          [4 ] Hospital de Cruces, Bilbao, Spain.
          [5 ] Hospital Vall d'Hebron, Barcelona, Spain.
          [6 ] INIBIC-Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
          [7 ] Hospital Universitario Marqués de Valdecilla, Santander, Spain.
          [8 ] Facultad de Medicina, Universidad de Cantabria, Santander, Spain.
          [9 ] Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
          [10 ] IRYCIS, Hospital Universitario Ramón y Cajal, Madrid, Spain.
          [11 ] TiGenix, Madrid, Spain.
          [12 ] Department of Medicine, Universidad de La Laguna, La Laguna, Spain.
          [13 ] Complejo Hospitalario Universitario de Canarias, Tenerife, Spain.
          Article
          annrheumdis-2015-208918
          10.1136/annrheumdis-2015-208918
          27269294
          c48cce07-9a9b-4662-a01f-5820eadeee04
          History

          B cells,Rheumatoid Arthritis,T Cells,Treatment
          B cells, Rheumatoid Arthritis, T Cells, Treatment

          Comments

          Comment on this article